489 related articles for article (PubMed ID: 19932713)
1. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
Newton R; Leigh R; Giembycz MA
Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
[TBL] [Abstract][Full Text] [Related]
2. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
3. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists.
Rider CF; King EM; Holden NS; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2011 Sep; 338(3):860-9. PubMed ID: 21622733
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease.
Moodley T; Wilson SM; Joshi T; Rider CF; Sharma P; Yan D; Newton R; Giembycz MA
Mol Pharmacol; 2013 Apr; 83(4):894-906. PubMed ID: 23389862
[TBL] [Abstract][Full Text] [Related]
7. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
8. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
Kiri VA; Bettoncelli G; Testi R; Viegi G
Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticosteroids.
Barnes PJ
Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
[TBL] [Abstract][Full Text] [Related]
12. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
Lindmark B
Ther Adv Respir Dis; 2008 Oct; 2(5):279-99. PubMed ID: 19124378
[TBL] [Abstract][Full Text] [Related]
13. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucocorticoids on gene transcription.
Hayashi R; Wada H; Ito K; Adcock IM
Eur J Pharmacol; 2004 Oct; 500(1-3):51-62. PubMed ID: 15464020
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of glucocorticoids in asthma].
Jaffuel D; Mathieu M; Godard P; Michel FB; Demoly P
Rev Mal Respir; 1999 Sep; 16(4):431-42. PubMed ID: 10549054
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory glucocorticoids: changing concepts.
Newton R
Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
[TBL] [Abstract][Full Text] [Related]
17. Targeting inflammation using selective glucocorticoid receptor modulators.
De Bosscher K; Haegeman G; Elewaut D
Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
[TBL] [Abstract][Full Text] [Related]
18. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells.
BinMahfouz H; Borthakur B; Yan D; George T; Giembycz MA; Newton R
Mol Pharmacol; 2015 Jan; 87(1):64-76. PubMed ID: 25324049
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
van der Velden VH
Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
[TBL] [Abstract][Full Text] [Related]
20. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]